Novo Nordisk unveiled a 2030 blockbuster drug plan, signaling long-term pipeline catalyst.
Why it matters
Novo Nordisk unveiled a 2030 blockbuster drug plan, signaling long-term pipeline catalyst. — impact context not separately stored; see What changed.